Characterization of ML-IAP protein stability and physiological role in vivo

Eugene Varfolomeev1, Elham Moradi, Jasmin N Dynek

  • 1Department of Early Discovery Biochemistry, Genentech Inc., South San Francisco, CA 94080, USA.

Insights

Melanoma inhibitor of apoptosis (ML-IAP) protein degradation is induced by bivalent antagonists, independent of other IAPs. ML-IAP is dispensable for normal mouse development and eye homeostasis.

Area of Science:

  • Molecular biology
  • Cancer research
  • Ophthalmology

Background:

  • Melanoma inhibitor of apoptosis (ML-IAP) is an anti-apoptotic protein highly expressed in melanomas, contributing to therapeutic resistance.
  • Inhibitor of Apoptosis (IAP) proteins are attractive targets for cancer therapeutics due to their roles in cancer progression.
  • Small-molecule IAP antagonists targeting baculovirus IAP repeat (BIR) domains can induce proteasomal degradation of c-IAP1 and c-IAP2.

Purpose of the Study:

  • To investigate the degradation of ML-IAP in response to IAP antagonists.
  • To determine the role of ML-IAP in normal mammalian tissues, particularly the eye.
  • To assess the necessity of ML-IAP for normal mouse development and ocular function.

Main Methods:

  • Treatment of cells with bivalent and monovalent small-molecule IAP antagonists.
  • Assessment of ML-IAP proteasomal degradation.
  • Analysis of ML-IAP ubiquitin ligase activity.
  • Examination of ML-IAP expression in normal mammalian tissues.
  • Phenotypic analysis of gene-targeted mice lacking ML-IAP.

Main Results:

  • ML-IAP undergoes proteasomal degradation in response to bivalent, but not monovalent, IAP antagonists.
  • This degradation is dependent on ML-IAP's intrinsic ubiquitin ligase activity and independent of c-IAP1 or c-IAP2.
  • ML-IAP expression in normal tissues is primarily restricted to the eye (ciliary body epithelium and retinal pigment epithelium).
  • Mice lacking ML-IAP display normal intraocular pressure, retinal structure, and function.

Conclusions:

  • Bivalent IAP antagonists can induce ML-IAP degradation through its own ubiquitin ligase activity.
  • ML-IAP is not essential for maintaining normal ocular homeostasis or overall mouse development.
  • ML-IAP may represent a therapeutic target in specific cancers, but its dispensability in normal tissues warrants further investigation.

Related Concept Videos

Bacterial Protein Maturation01:26

Bacterial Protein Maturation

Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...